News
The Knight Family DIAN-TU-003 Amyloid Removal Trial
MEMO DATE: 15 April 2024 TO: DIAN-TU-001 Gantenerumab Open Label Extension Participants FROM: Dr. Randall Bateman, Director, Knight Family DIAN-TU...
The Knight Family DIAN-TU Primary Prevention Trial Announcement
The statement below is an update to the 20 December 2022 announcement by the Knight Family Dominantly Inherited Alzheimer Network...
The New Age of Alzheimer’s
Scientific American- Apr 18, 2024
Moment of promise
The Source, Washington University in St. Louis - Apr 15, 2024
Alzheimer’s Association and GHR Foundation Commit $4 Million to Extend Prevention Trial in Rare Alzheimer’s
Alzheimer's Association press release - Apr 9, 2024
Alzheimer’s blood test performs as well as FDA-approved spinal fluid tests
The Source, Washington University in St. Louis - Feb 21, 2024 The Knight Family DIAN-TU Amyloid Removal Trial
The statement below is an update to the 18 August 2023 announcement by the Knight Family Dominantly Inherited Alzheimer Network...
Can We Prevent Alzheimer’s? Scientists Say New Tests and Treatments are “a Game Changer”
Un nouveau traitement prometteur contre l’Alzheimer précoce
Podcast: Newly approved drug may slow progression of Alzheimer’s